Skip to main content
Zentek Ltd. logo

Zentek Ltd. — Investor Relations & Filings

Ticker · ZTEK TSXV Professional, scientific and technical activities
Open in API
Filings indexed 667 across all filing types
Latest filing 2020-06-17 Capital/Financing Update
Country CA Canada
Listing TSXV ZTEK

About Zentek Ltd.

https://www.zentek.com/

Zentek Ltd. is an intellectual property development and commercialization company focused on applying advanced nanotechnology and nanomaterials, specifically graphene, to solve complex challenges in health, safety, and the environment. The company specializes in developing and commercializing next-generation healthcare solutions across prevention, detection, and treatment. Zentek utilizes strategic partnerships to advance its patented nanotechnologies. A key commercialized product is ZenGUARD™, an antimicrobial coating that employs a graphene-silver combination to significantly enhance viral and bacterial filtration performance in applications such as surgical masks and air filters.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing expressions of interest for a non-brokered private placement of units by ZEN Graphene Solutions Ltd. It discusses the amount of interest received, the intended use of proceeds, and the next steps including Exchange approval and closing. There are no financial statements or detailed financial data presented, nor is this a full report or regulatory filing. The content focuses on fundraising activity and capital raising. The document length is 4202 characters, which is relatively short and typical for an announcement rather than a full report. Therefore, this document fits best under the category of Capital/Financing Update (CAP).
2020-06-17 English
News release - English.pdf
Capital/Financing Update Classification · 100% confidence The document is a press release announcing a non-brokered private placement of units by ZEN Graphene Solutions Ltd. It details the offering terms, use of proceeds, and regulatory approval required from the TSX Venture Exchange. There are no financial statements, quarterly or annual results, or detailed financial analysis present. The document is short (4307 characters) and serves as a capital raising announcement rather than a full financial report or earnings release. Therefore, it fits the category of Capital/Financing Update (CAP).
2020-06-15 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Form 51-102F3 Material Change Report' and contains detailed information about a material change event dated June 12, 2020. It includes a news release about the company's first results from graphene oxide silver nanoparticle ink formulations, which is a significant operational update. The form references National Instrument 51-102, which governs continuous disclosure obligations for Canadian reporting issuers, specifically material change reports. The document is not a full annual or quarterly report, audit report, or earnings release. It is a regulatory filing disclosing a material change event to the market. The length is about 5,491 characters, which is consistent with a detailed material change report rather than a brief announcement. Therefore, the document fits best under Regulatory Filings (RNS), as it is a material change report filed under Canadian securities regulations and does not fit other more specific categories like earnings release or management report.
2020-06-12 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing initial test results of graphene oxide silver nanoparticle ink formulations by ZEN Graphene Solutions. It discusses scientific testing outcomes related to virucidal efficacy against COVID-19 and future product development plans. There is no indication of financial data, regulatory filings, shareholder votes, management changes, or detailed financial reports. The content is a corporate announcement of research results rather than a formal financial or regulatory filing. Therefore, it best fits the category of a Regulatory Filing (RNS) as a general announcement that does not fit other specific categories.
2020-06-11 English
News release - English.pdf
Regulatory Filings
2020-06-09 English
News release - English.pdf
Regulatory Filings
2020-06-08 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.